An Overview of the Heterogeneity of Major Depressive Disorder: Current Knowledge and Future Prospective.

Abstract:

:Major depressive disorder (MDD) is estimated to impose maximum debilitating effects on the society by 2030, with its critical effects on health, functioning, quality of life and concomitant high levels of morbidity and mortality. Yet, the disease is inadequately understood, diagnosed and treated. Moreover, with the recent drastic rise in the pace of life, stress has materialized as one of the most potent environmental factors for depression. In this scenario, it is important to understand the modern pathogenetic hypotheses and mechanisms, and possibly try to shift from the traditional approaches in depression therapy. These include the elaboration of pathophysiological changes in heterogeneous systems such as genetic, epigenetic, serotonergic, noradrenergic, gammaaminobutyric acid, glutamatergic and endocannabinoid systems, neurotrophic factors, HPA axis, immune system as well as cellular stress mechanisms. These components interact with each other in a complex matrix and further elucidation of their mechanism and cascade pathways are needed. This might aid in the identification of MDD subtypes as well as the development of sophisticated biomarkers. Further, characterization might also aid in developing multitargeted therapies that hold much promise as compared to the conventional monoamine based treatment. New candidate pharmacons, refined psychotherapeutic modalities, advanced neuro-surgical and imaging techniques as well as the implementation of pharmacokinetic, pharmacogenetic prescribing guidelines constitute the emerging expanses of MDD treatment.

journal_name

Curr Neuropharmacol

authors

Athira KV,Bandopadhyay S,Samudrala PK,Naidu VGM,Lahkar M,Chakravarty S

doi

10.2174/1570159X17666191001142934

subject

Has Abstract

pub_date

2020-01-01 00:00:00

pages

168-187

issue

3

eissn

1570-159X

issn

1875-6190

pii

CN-EPUB-101112

journal_volume

18

pub_type

杂志文章,评审
  • Optic Nerve and Cerebral Edema in the Course of Diabetic Ketoacidosis.

    abstract::In the recent years we have been observing an increased incidence of type 1 diabetes in children and adolescents. This leads to a more frequent acute complication of type 1 diabetes among children with hyperglycemia. The most common of these is diabetic ketoacidosis (DKA), while cerebral edema is the most dangerous. I...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159x14666160225155151

    authors: Szmygel Ł,Kosiak W,Zorena K,Myśliwiec M

    更新日期:2016-01-01 00:00:00

  • Roles of TRAF6 in Central Nervous System.

    abstract::Tumor necrosis factor receptor-associated factor (TRAF) is an important binding protein of tumor necrosis factor (TNF) superfamily and the toll/IL-1 receptor (TIR) superfamily, which play an important role in innate immunity and acquired immunity. TRAFs family have 7 members (TRAF1-7), and TRAF6 has its special factur...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159X16666180412094655

    authors: Dou Y,Tian X,Zhang J,Wang Z,Chen G

    更新日期:2018-01-01 00:00:00

  • Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage.

    abstract::Alzheimer's disease, Parkinson's disease, traumatic brain and spinal cord injury and neuroinflammatory multiple sclerosis are diverse disorders of the central nervous system. However, they are all characterized by various levels of inappropriate inflammatory/immune response along with tissue destruction. In the gastro...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159x14666160121115210

    authors: Földes A,Kádár K,Kerémi B,Zsembery Á,Gyires K,S Zádori Z,Varga G

    更新日期:2016-01-01 00:00:00

  • Use of Push-Pull Superfusion Technique for Identifying Neurotransmitters Involved in Brain Functions: Achievements and Perspectives.

    abstract::The push-pull superfusion technique (PPST) is a procedure for in vivo examination of transmitter release in distinct brain areas. This technique allows to investigate dynamics of transmitter release both under normal and experimentally evoked conditions. The PPST can be modified so that it is possible to determine rel...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159x13666150722233149

    authors: Kraus MM,Philippu A

    更新日期:2015-01-01 00:00:00

  • Exploiting the diversity of the heat-shock protein family for primary and secondary tauopathy therapeutics.

    abstract::The heat shock protein (Hsp) family is an evolutionarily conserved system that is charged with preventing unfolded or misfolded proteins in the cell from aggregating. In Alzheimer's disease, extracellular accumulation of the amyloid β peptide (Aβ) and intracellular aggregation of the microtubule associated protein tau...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015911798376226

    authors: Abisambra JF,Jinwal UK,Jones JR,Blair LJ,Koren J 3rd,Dickey CA

    更新日期:2011-12-01 00:00:00

  • Autoimmune channelopathies of the nervous system.

    abstract::Ion channels are complex transmembrane proteins that orchestrate the electrical signals necessary for normal function of excitable tissues, including the central nervous system, peripheral nerve, and both skeletal and cardiac muscle. Progress in molecular biology has allowed cloning and expression of genes that encode...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015911796557966

    authors: Kleopa KA

    更新日期:2011-09-01 00:00:00

  • Proteomic analysis of glioma chemoresistance.

    abstract::Malignant glioma is the most common and destructive form of primary brain tumor. Along with surgery and radiation, chemotherapy remains as the major treatment modality. The emergence of drug resistance, however, often leads to a therapeutic failure in the treatment of glioma, precluding long-term survival of the patie...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015912799362733

    authors: Suk K

    更新日期:2012-03-01 00:00:00

  • Neuroprotection: the emerging concept of restorative neural stem cell biology for the treatment of neurodegenerative diseases.

    abstract::During the past decades Neural Stem Cells have been considered as an alternative source of cells to replace lost neurons and NSC transplantation has been indicated as a promising treatment for neurodegenerative disorders. Nevertheless, the current understanding of NSC biology suggests that, far from being mere spare p...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015911795596603

    authors: Carletti B,Piemonte F,Rossi F

    更新日期:2011-06-01 00:00:00

  • Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

    abstract::Targeting analgesic drugs for spinal delivery reflects the fact that while the conscious experience of pain is mediated supraspinally, input initiated by high intensity stimuli, tissue injury and/or nerve injury is encoded at the level of the spinal dorsal horn and this output informs the brain as to the peripheral en...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159x14666160307145542

    authors: Yaksh TL,Fisher CJ,Hockman TM,Wiese AJ

    更新日期:2017-01-01 00:00:00

  • Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson's Disease.

    abstract::Autophagy is a cellular quality control mechanism crucial for neuronal homeostasis. Defects in autophagy are critically associated with mechanisms underlying Parkinson's disease (PD), a common and debilitating neurodegenerative disorder. Autophagic dysfunction in PD can occur at several stages of the autophagy/lysosom...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159x13666151030103027

    authors: Rivero-Ríos P,Madero-Pérez J,Fernández B,Hilfiker S

    更新日期:2016-01-01 00:00:00

  • The sigma receptor: evolution of the concept in neuropsychopharmacology.

    abstract::Although originally proposed as a subtype of opioid receptors, the sigma receptor is now confirmed to be a non-opioid receptor that binds diverse classes of psychotropic drugs. Sigma receptors are subdivided into two subtypes, sigma-1 and sigma-2. The sigma-1 receptor is a 25-kDa protein possessing one putative transm...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015905774322516

    authors: Hayashi T,Su T

    更新日期:2005-10-01 00:00:00

  • May exercise prevent addiction?

    abstract::Amphetamines exert their persistent addictive effects by activating brain's reward pathways, perhaps through the release of dopamine in the nucleus accumbens (and/or in other places). On the other hand, there is a relationship between dopamine and all behavioural aspects that involve motor activity and it has been dem...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015911795017380

    authors: Fontes-Ribeiro CA,Marques E,Pereira FC,Silva AP,Macedo TR

    更新日期:2011-03-01 00:00:00

  • Traumatic Brain Injury: A Forensic Approach: A Literature Review.

    abstract::Traumatic brain injury (TBI) is the principal cause of invalidity and death in the population under 45 years of age worldwide. This mini-review aims to systematize the forensic approach in neuropathological studies, highlighting the proper elements to be noted during external, radiological, autoptical, and histologica...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X17666191101123145

    authors: Bertozzi G,Maglietta F,Sessa F,Scoto E,Cipolloni L,Di Mizio G,Salerno M,Pomara C

    更新日期:2020-01-01 00:00:00

  • MicroRNAs: The New Challenge for Traumatic Brain Injury Diagnosis.

    abstract::The acronym TBI refers to traumatic brain injury, an alteration of brain function, or an evidence of brain pathology, that is caused by an external force. TBI is estimated to become the third leading cause of permanent disability and mortality worldwide. TBI-related injuries can be classified in many ways, according t...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159X17666191113100808

    authors: Pinchi E,Frati P,Arcangeli M,Volonnino G,Tomassi R,Santoro P,Cipolloni L

    更新日期:2020-01-01 00:00:00

  • Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications.

    abstract::Temozolomide (TMZ), an oral alkylating prodrug which delivers a methyl group to purine bases of DNA (O6- guanine; N7-guanine and N3-adenine), is frequently used together with radiotherapy as part of the first-line treatment of high-grade gliomas. The main advantages are its high oral bioavailability (almost 100% altho...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X18666200626204005

    authors: Ortiz R,Perazzoli G,Cabeza L,Jiménez-Luna C,Luque R,Prados J,Melguizo C

    更新日期:2020-06-26 00:00:00

  • From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings.

    abstract::During the last decade, several meta-analytic studies employing different methodological approaches have had inconsistent conclusions regarding antidepressant efficacy. Herein, we aim to comment on methodological aspects that may have contributed to disparate findings. We initially discuss methodological inconsistenci...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,meta分析

    doi:10.2174/1570159x13666150630174343

    authors: Fountoulakis KN,McIntyre RS,Carvalho AF

    更新日期:2015-01-01 00:00:00

  • Revolutionary impact of nanodrug delivery on neuroscience.

    abstract::Brain research is the most expanding interdisciplinary research that is using the state of the art techniques to overcome limitations in order to conduct more accurate and effective experiments. Drug delivery to the target site in the central nervous system (CNS) is one of the most difficult steps in neuroscience rese...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015912804143513

    authors: Khanbabaie R,Jahanshahi M

    更新日期:2012-12-01 00:00:00

  • Aquaporin biology and nervous system.

    abstract::Our understanding of the movement of water through cell membranes has been greatly advanced by the discovery of a family of water-specific, membrane-channel proteins: the Aquaporins (AQPs). These proteins are present in organisms at all levels of life, and their unique permeability characteristics and distribution in ...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015910791233204

    authors: Buffoli B

    更新日期:2010-06-01 00:00:00

  • Potential effects of cannabidiol as a wake-promoting agent.

    abstract::Over the last decades, the scientific interest in chemistry and pharmacology of cannabinoids has increased. Most attention has focused on ∆(9)-tetrahydrocannabinol (∆(9)-THC) as it is the psychoactive constituent of Cannabis sativa (C. sativa). However, in previous years, the focus of interest in the second plant cons...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X11666131204235805

    authors: Murillo-Rodríguez E,Sarro-Ramírez A,Sánchez D,Mijangos-Moreno S,Tejeda-Padrón A,Poot-Aké A,Guzmán K,Pacheco-Pantoja E,Arias-Carrión O

    更新日期:2014-05-01 00:00:00

  • The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacology.

    abstract::Changes of the tumor necrosis factor-alpha (TNF-alpha) system have been shown to be involved in the development of psychiatric disorders and are additionally associated with changes in body weight as well as endocrine and metabolic changes in psychiatric patients. TNF-alpha might, for example, contribute to the pathog...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015908785777238

    authors: Berthold-Losleben M,Himmerich H

    更新日期:2008-09-01 00:00:00

  • Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias.

    abstract:BACKGROUND:Hereditary cerebellar ataxias are a group of disorders characterized by heterogeneous clinical manifestations, progressive clinical course, and diverse genetic causes. No disease modifying treatments are yet available for many of these disorders. Oxidative stress has been recurrently identified in different ...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159X15666171109125643

    authors: Barca E,Emmanuele V,DiMauro S,Toscano A,Quinzii CM

    更新日期:2019-01-01 00:00:00

  • Clearing the brain's cobwebs: the role of autophagy in neuroprotection.

    abstract::Protein aggregates or inclusion bodies are common hallmarks of age-related neurodegenerative disorders. Why these aggregates form remains unclear. Equally debated is whether they are toxic, protective, or simple by-products. Increasing evidence, however, supports the notion that in general aggregates confer toxicity a...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015908784533897

    authors: Bossy B,Perkins G,Bossy-Wetzel E

    更新日期:2008-06-01 00:00:00

  • Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine.

    abstract:BACKGROUND:Over 100 people die daily from opioid overdose and $78.5B per year is spent on treatment efforts, however, the real societal cost is multifold greater. Alternative strategies to eradicate/manage drug misuse and addiction need consideration. The perception of opioid addiction as a social/criminal problem has ...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X17666191118125702

    authors: Abijo T,Blum K,Gondré-Lewis MC

    更新日期:2020-01-01 00:00:00

  • Recent Trends in the Management of Alzheimer's Disease: Current Therapeutic Options and Drug Repurposing Approaches.

    abstract::Alzheimer's disease is one of the most progressive forms of dementia, ultimately leading to death in aged populations. The major hallmarks of Alzheimer's disease include deposition of extracellular amyloid senile plaques and intracellular neurofibrillary tangles in brain neuronal cells. Although there are classical th...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X18666200128121920

    authors: Singh RK

    更新日期:2020-01-01 00:00:00

  • Modelling anxiety in humans for drug development.

    abstract::Animal behavioural profiles are commonly employed to investigate new therapeutic agents to treat anxiety disorders as well as to investigate the mechanism of action of anxiolytic drugs. However, many clinically important symptoms of anxiety can not be modelled directly in animals. Human models of anxiety should bridge...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015907780077114

    authors: Siepmann M,Joraschky P

    更新日期:2007-03-01 00:00:00

  • Effects of risperidone in autistic children and young adults: A Systematic Review and Meta-Analysis.

    abstract::There are several studies investigating the effects of risperidone in autism, but many of these studies are contradictory or inconclusive. This systematic review and meta-analysis investigated the effects of risperidone on five domains of Aberrant Behaviour Checklist (ABC) scale on Autism Spectrum Disorder (ASD), as w...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X18666200529151741

    authors: Mano-Sousa BJ,Pedrosa AM,Alves BC,Galduróz JCF,Belo VS,Chaves VE,Duarte-Almeida JM

    更新日期:2020-05-29 00:00:00

  • Current experimental therapy for Alzheimer's disease.

    abstract::In the past decade, enormous efforts have been devoted to understand the genetics and molecular pathogenesis of Alzheimer's disease (AD), which has been transferred into extensive experimental approaches aimed at reversing disease progression. The trend in future AD therapy has been shifted from traditional anti-acety...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015907780866901

    authors: Chen S,Zhang XJ,Li L,Le WD

    更新日期:2007-01-01 00:00:00

  • Altered Mesolimbic Dopamine System in THC Dependence.

    abstract::To explore the functional consequences of cannabinoid withdrawal in the rat mesolimbic dopamine system, we investigated the anatomical morphology of the mesencephalic, presumed dopaminergic, neurons and their main post-synaptic target in the Nucleus Accumbens. We found that TH-positive neurons shrink and Golgi-stained...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/157015911795017083

    authors: Spiga S,Lintas A,Diana M

    更新日期:2011-03-01 00:00:00

  • Insights Into the Molecular Aspects of Neuroprotective Bacoside A and Bacopaside I.

    abstract::Bacopa monnieri, commonly known as Brahmi, has been extensively used as a neuromedicine for various disorders such as anxiety, depression and memory loss. Chemical characterization studies revealed the major active constituents of the herb as the triterpenoid saponins, bacosides. Bacoside A, the vital neuroprotective ...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章,评审

    doi:10.2174/1570159X16666180419123022

    authors: Sekhar VC,Viswanathan G,Baby S

    更新日期:2019-01-01 00:00:00

  • Tyrosol as a neuroprotector: strong effects of a "weak" antioxidant.

    abstract::The use of neuroprotective agents for stroke is pathogenetically justified, but the translation of results of preclinical studies of neuroprotectors into clinical practice has been a noticeable failure. One of the leading reasons for these failures is the one-target mechanism of their activity. p-Tyrosol (Tyr), a biop...

    journal_title:Current neuropharmacology

    pub_type: 杂志文章

    doi:10.2174/1570159X18666200507082311

    authors: Plotnikov MB,Plotnikova TM

    更新日期:2020-05-06 00:00:00